Open AccessSerum Malondialdehyde as a Biomarker of Oxidative Stress in Patients with Primary Ocular Carcinoma: Impact on Response to Chemotherapy
Author(s) -
Rajendra P Maurya,
Manish Prajapat,
Virendra Singh,
Meera Roy,
Ravina Todi,
Sanjay Kumar Bosak,
Sunit K. Singh,
Seema Chaudhary,
Anil Kumar,
Sunil R Morekar
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s287747
Subject(s) - medicine , malondialdehyde , malignancy , chemotherapy , biomarker , retinoblastoma , gastroenterology , pathology , oxidative stress , oncology , biochemistry , chemistry , gene
To study the level of serum malondialdehyde (MDA), a biomarker of oxidative stress before and after chemotherapy in various ocular malignancies and to correlate its significance with clinicopathological parameters.